Background. There are logistical and financial advantages to undertaking shoulder surgery in a day case setting. However, this approach is limited by postoperative pain being inadequately controlled by oral medication alone. We describe a pilot study investigating the feasibility and acceptance of community based continuous interscalene brachial plexus blockade (CIBPB) to provide effective analgesia for day case shoulder surgery.
necessary for patients to remain in hospital and they can be managed on a day-stay basis. A few centres around the world have recognized the advantages in doing this and have reported successful results. [4] [5] [6] [7] [8] The purpose of this pilot study was to see if we could do this in the UK state-supported healthcare setting.
Methods
Local Research Ethics Committee approval was gained for this study, and all subjects provided written, informed consent. The project was jointly supported by the Queen Elizabeth Hospital Trust, Kings Lynn (QEH) and the West Norfolk Primary Care Trust. A multidisciplinary team was formed from hospital staff and primary health care staff. In addition to a consultant anaesthetist and a consultant surgeon, the team included orthopaedic preoperative assessment nurses, the Clinical Fellow in Regional Anaesthesia, the Discharge Liaison Sister (who liaised with the district nurses) and the Clinical Effectiveness Manager (who interviewed the patients in their homes after completion of their treatment).
Other staff who were not part of the immediate team but who needed to be kept informed, included ward managers, ward staff, the Directorate Manager, the Chief Pharmacist, the Medical Devices Officer and operating theatre staff and District Nurses. Throughout the project there were monthly multidisciplinary team meetings. Initially, a process map of the patient journey was made to identify the changes necessary to the established practice and to format the changes that would be needed to develop an appropriate patient care plan. Documentation was developed before the project was started. This included a list of requirements (Appendix 1), detailed patient information leaflets and a list of telephone numbers that would allow patients to access 24 h support.
The study comprised two phases. Phase 1 consisted of trialling the proposed care plan on in-patients, who stayed in hospital for one night and were discharged on the day after surgery. If formal assessment of the results of Phase 1 indicated that the process had been safe and successful, then Phase 2 could proceed, with patients being discharged home with an interscalene catheter in situ on the day of surgery.
Phase 1
Five subjects were studied in Phase 1. Inclusion criteria for the study comprised all patients undergoing major shoulder surgery for which the surgeon and anaesthetist agreed that postoperative CRA would be appropriate. In addition, the patients had to fulfil all of our current day surgery criteria, which included: ASA I-III, BMI <38 kg m
À2
, living within 20 miles of the hospital, having a means of transport, an accompanying adult at home and access to a telephone.
Potential patients for the study were identified from an inpatient waiting list. A brief telephone assessment of these patients was undertaken by the orthopaedic preoperative assessment nurse to ensure that patients met the day case criteria before they were approached about taking part in the trial. These patients were then formally pre-assessed 2 weeks before surgery. The patients and their carers were given clear instructions about the care of the interscalene catheter, local anaesthetic infusion pump and their numb arm.
In the anaesthetic room, the patients were monitored with an ECG, pulse oximeter and automated non-invasive blood pressure. An i.v. cannula was inserted. An interscalene brachial plexus catheter was inserted under sedation with a target-controlled infusion of propofol. A 'catheterthrough-needle' technique was used to place the interscalene catheters as described previously. 9 The equipment used was a Contiplex Tuohy kit (B. Braun, Melsungen, Germany). When contractions in the target muscle (biceps/brachialis) were evoked at a stimulus duration of 0.1 ms and a current of <0.5 mA, ropivacaine 0.75% 30-40 ml was injected. The 20G end-hole catheter was then placed, and a test dose of lidocaine 1% with 1:200 000 epinephrine 5 ml was injected down the catheter to exclude intravascular placement. The catheter was tunnelled subcutaneously medially towards the sternal notch and secured with an epidural catheter clamp (Lokit, Smiths Medical, Hythe, UK). The surgical procedures were performed under sedation or general anaesthesia according to the patients' preference.
Patient-controlled CRA was started after surgery. Plain ropivacaine 0.2% was infused at a background rate of 9 ml h À1 via an Abbott Gemstar pump (Abbott Laboratories Ltd, Queenborough, UK). Patients had an option of receiving a bolus of 5 ml for breakthrough pain with a lockout period of 30 min. All patients took regular oral diclofenac (slow release 75 mg twice a day) and cocodamol (30/500 mg four times a day) after surgery. Pain control, catheter and infusion pump function and patient suitability for discharge was assessed on the morning after surgery (Appendix 2). If patients were judged suitable for discharge, they were given written instructions on the management of the pump, the contact numbers of the District Nurses and a letter for their General Practitioner.
A District Nurse visited each patient in the evening after discharge (about 30 min), and twice daily thereafter (60 min in the morning and a few minutes in the evening) to check on them, assess pain, redress the wound, assist with the exercises and change the infusion bag if necessary. The District Nurse removed the catheter on the third day after surgery.
Phase 2
Five subjects were studied in Phase 2. Patient assessment and enrolment were as for Phase 1. The ISBPB was induced with prilocaine 1% 30-40 ml rather than ropivacaine. At the end of the operation, a bolus injection of ropivacaine 0.2% was injected down the catheter, followed by its attachment to a disposable patient-controlled CRA pump (Baxter disposable pump, Compton, UK). The fixed pump settings used in Phase 2 were: ropivacaine 0.2%, background infusion of 7 ml h À1 ; bolus of 5 ml; lockout period of 30 min. Patients
were assessed 4 h after surgery and were discharged if they met the discharge criteria. Other elements of their postoperative management were as for Phase 1.
Results

Phase 1
Patient characteristics and the procedures they underwent are presented in Table 1 . All the ISBPBs were successful, all interscalene catheters worked well, in that they provided good analgesia. The electronic pumps malfunctioned in three cases (battery failure and air alarms for small amounts of air). These problems necessitated additional District Nurse visits. Postoperative semi-structured discovery interviews by the Clinical Effectiveness Team at the patient's home showed that all the patients were satisfied with their management. However, the patients presumed that they would be pain-free after the catheter had been removed. Unfortunately, this was not the case.
Phase 2
Patient characteristics and the procedures they underwent are presented in Table 2 . All the ISBPBs were successful, all interscalene catheters worked well in that they provided good analgesia. One catheter dislodged shortly after the patient had been discharged home. The patient was readmitted to hospital for pain management. The Clinical Effectiveness Manager visited the patients at home after operation and conducted semi-structured discovery interviews that showed that all the patients were satisfied with their management. One patient felt that his recovery was quicker when compared with his previous identical shoulder operation as an in-patient.
Discussion
A few centres outside the UK have described the use of postoperative interscalene CRA at home. [4] [5] [6] [7] [8] The aim of this pilot study was to see whether it was feasible in the UK state-funded health setting. The challenges facing us were complex; including patient selection, achieving adequate analgesia, the selection of suitable pumps, the creation of patient care pathways and providing adequate nursing backup for the patient at home, as well as working across primary and secondary care Trusts and forming a liaison with the community nurses. We chose to perform the study in two phases because by keeping patients in hospital for one night in Phase 1, we were able to assess the quality of the analgesia and the reliability of the infusion equipment before proceeding to Phase 2. The electronic pumps used in Phase 1 proved not to be reliable, so elastomeric disposable pumps were used for Phase 2. These functioned very well.
Although previous reports of CRA at home did not include visits by trained nurses, [4] [5] [6] we felt that this was an important part of guaranteeing the safety and efficacy of the system while ensuring that backup facilities were available if there were problems with analgesia. It was essential that the nurses had clear guidelines, including a readmission policy, and had appropriate support available. Although previous reports of interscalene catheters describe the patient removing their own catheter, 4 5 we chose to have District Nurses do this. They could then either return the electronic pump to the hospital (Phase 1) or dispose of the elastomeric pumps appropriately (Phase 2), and forward any assessment documentation to the POSSI Team.
We based our dose regimen on the studies that have shown ropivacaine infusions to be safe and effective in this setting. 5 9 11 However, during Phase 1 we became aware of an analgesic gap that occurred as the initial injection of ropivacaine 0.75% wore off at about 16 h after block insertion, often in the early hours of the morning. This phenomenon has been reported before. 9 If patients were to be sent home on the day of surgery, the analgesic gap would occur at home when there was no healthcare professional immediately to hand to help. Hence, we changed the local anaesthetic we used to establish the surgical block from ropivacaine 0.75% to prilocaine 1%. The short duration of this drug meant that if the catheter infusion did not provide adequate analgesia, then this would have become apparent before the patient was discharged. This strategy appeared to work well: there were no analgesic gaps recorded. Catheter failure or dislodgement is a common complication of CRA. Although our catheters are securely fixed as described above, one patient experienced catheter failure and required readmission for pain control. This event demonstrated the need for a readmission policy and proved it worked effectively.
Sending patients home with medical devices attached to them raises the issue of patient safety. The pump infusion rates we chose were based on published data that indicated that the doses administered were very unlikely to be associated with systemic local anaesthetic toxicity. 12 13 An important safety feature of elastomeric pumps is that they include a high flow resistance that prevents 'dumping' of large amounts of local anaesthetic into the patient, which might produce systemic toxicity. In addition, these pumps have an easily activated clamp that the patient can use to stop the infusion if signs or symptoms of local anaesthetic toxicity develop. We were also reassured by the twice-daily visits of trained nursing staff and the presence of a 24 h on call service.
The POSSI project proved successful, albeit with small numbers of patients. Its safe implementation involved a lot of planning and hard work by a large multidisciplinary team. However, we were sufficiently encouraged by our results to turn this pilot study into a properly funded service. Efficiency savings proved popular with hospital managers. Most importantly it was deemed to be successful by patients and by community nurses who found it easy and satisfying to care for these patients in their own homes. 7. All documentation produced must be sent to the Trust's reading panels, Clinical Governance panels and the relevant managers for approval-numerous changes may have to be made for this to occur. 8. Identification of key trainers for pump training for primary care (District Nurses), secondary care (ward staff, theatre staff) and the patients. 9. Issues with regard to funding should be discussedpatients are moving from secondary care to primary care. 10. A business plan to address these issues. 11. Regular team meetings to discuss issues and update each other on the current situation. 12. Once the final decision is made to start a project, the identification of patients suitable for the trial. 13. After the trial has started, continuous audit of processes and outcome. Patients and staff should be asked for input about system changes that would increase safety and effectiveness. 
Consultant
